Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines

BACKGROUND: Urothelial carcinoma (UC) accounts for > 90% of canine tumors occurring in the urinary bladder. Toceranib phosphate (TOC) is a multi-target receptor tyrosine kinase (RTK) inhibitor that exhibits activity against members of the split kinase family of RTKs. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Korec, Daniela I., Louke, Darian S., Breitbach, Justin T., Geisler, Jennifer A., Husbands, Brian D., Fenger, Joelle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487586/
https://www.ncbi.nlm.nih.gov/pubmed/34600548
http://dx.doi.org/10.1186/s12917-021-03027-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487586/
https://www.ncbi.nlm.nih.gov/pubmed/34600548
http://dx.doi.org/10.1186/s12917-021-03027-0

Ejemplares similares